Activity Release Date: 04/23/2021
Activity Expiration Date: 04/22/2022
1.0 hour activity | ACCME/ ABIM MOC, ANCC, AAPA
dandelionRX’s activity, “Communication and shared decision making: How to have better conversations with people who have endometrial cancer”, aims to provide new skills for healthcare teams to discuss a diagnosis of endometrial cancer and treatment plans with patients.
We will introduce you to a set of evidence-based communication principles and targeted strategies you can use to communicate with your patients. We will include first-hand experiences and insights from patients diagnosed with endometrial cancer, their caregivers and healthcare professionals, which informed these principles and strategies.
We’ll also share a set of communication tools developed with patients, caregivers, and healthcare professionals like you. These evidence-based, interactive materials are designed to support you as you make decisions with your patients.
Every provider brings their perspective, their experience, and their knowledge into their relationships with their patients. For that reason, these strategies may look very different when they’re used in different care settings. Throughout this module, we’ll ask you to reflect on your experience and consider how these strategies and tools might fit into your practice. We’ve asked these same questions to experienced healthcare professionals in oncology, and we’ll share their responses with you along the way.
When these communication principles, strategies and tools are used, the new patient is more likely to recall and understand information about their diagnosis and treatment options, and be more likely to follow their providers recommendations and adhere to treatment regimens. Healthcare providers will be able to build trust more quickly with their patients, leverage the full care team to ensure no concerns of the patient and their caregiver are left hanging, and spend less time repeating information. By supporting your patients as they come to terms with a major change in their lives, and helping them make informed decision about their future, you are providing high-quality care and assisting in charting a course that supports the patient’s overall health, no matter their prognosis.
This activity has been designed to meet the educational needs of oncologists, nurse practitioners, registered nurses, social workers, oncology nutritionists and others involved in the care of patients diagnosed with endometrial cancer.
Upon completion of the educational activity, participants should be able to:
- Identify barriers to productive communication between providers and patients during a diagnosis of endometrial cancer
- Articulate guiding principles and best practices for provider-patient communication, and use communication strategies to develop and support a therapeutic relationship with patients
Credit provided by AKH Inc
In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and dandelionRX. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of the CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.5 medical knowledge MOC points and 0 patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit
Credit being awarded: 1 ANCC contact hours
AAPA Credit Designation Statement
AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until April 22, 2022. PAs should only claim credit commensurate with the extent of their participation.
Criteria for Success
To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at [email protected]
ABOUT OUR FACULTY
Sharyn N. Lewin – MD, FACS, FACOG is a board certified Gynecologic Oncologist, specializing in the diagnosis, treatment, and management of ovarian, endometrial, uterine, cervical, vulvar, and vaginal cancers. She serves as Medical Director of the New Jersey-based Holy Name Medical Center’s Gynecologic Oncology Division. Her practice employs a comprehensive, multidisciplinary team approach to screening, treatment, and overall improvement in quality of care for women at high risk for ovarian cancer and other gynecologic malignancies. She is an Assistant Clinical Professor of Obstetrics and Gynecology in the Icahn School of Medicine Mount Sinai Hospital in New York.
Dr. Lewin’s expertise includes radical operations for ovarian cancer, including upper abdominal and extended pelvic resections. She has extensive training in minimally invasive laparoscopic procedures and robotic techniques using the da Vinci® Surgical System. She uses intraperitoneal chemotherapy and has research interests in novel chemotherapeutic agents, including immunotherapy and hyperthermic chemotherapy (HIPEC) for recurrent ovarian cancer.
Most recently, Dr. Lewin was an Assistant Clinical Professor and a member of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at Columbia University Medical Cancer, New York-Presbyterian Hospital (NYP), and a member of the Herbert Irving Comprehensive Cancer Center at Columbia University College of Physicians and Surgeons. While at NYP, Dr. Lewin was the first Medical Director of the Woman to Woman Program, a cancer support initiative.
She is also Founder and Executive Director of The Lewin Fund, responsible for the organization’s operations, and for setting its strategic vision. She is also the organization’s chief ambassador, responsible for advancing The Lewin Fund’s mission to invest in grassroots initiatives and research that directly support women who are afflicted with cancer and their families. She is a long-time advocate for women and women’s health and brings more than 19 years of medical, research, and community outreach experience to her role.
Dr. Lewin is a graduate of University of Kansas School of Medicine. She completed her internship and residency at Washington University School of Medicine/Barnes Jewish Hospital, St. Louis, MO, followed by a fellowship in gynecologic oncology at Memorial Sloan-Kettering Cancer Center, New York, NY.
A national educator on hereditary genetics, cancer survivorship and state-of-the-art treatment for advanced ovarian cancer, Dr. Lewin has authored or co-authored over 100 articles, abstracts, book chapters, and made many presentations at scholarly conferences. She is a recipient of the President’s Award from the Society of Gynecologic Oncology and NYP’s prestigious Physician of the Year Award.
Penny Daugherty, RN, MS, OCN, ONN-CG is a Gynecologic Oncology Nurse Navigator (ONN) at Northside Hospital Cancer Institute in Atlanta, GA and also works with Head and Neck patients needing ONN services. She served as Clinical Research Director of Southeastern Gynecologic Oncology for 10 years and participated in the National ONS team to create Core Competencies for Clinical Trial Nurses.
A founding member of Cancer Patient Navigators of Georgia (2009), Co-Chair of the annual CPNG conference since 2015 and currently serves as Co-Chair of the AONN+ Conference Planning Committee, Penny co-edited the first two comprehensive textbooks on Oncology Nurse Navigators.
As a registered nurse, with 40+ years of broad-based experience as a clinician, research coordinator, educator and director, Penny has the time-tested acumen to manage personnel and medical teams in support of comprehensive research environments.
One of Penny’s overarching goals is to educate and advocate for those in the midst of a crisis. A key touchpoint in her work is to restore the personal identity of her patients. She actively works on assisting people who are seeking to regain their sense of self during and after cancer treatment. She has made it her mission to offer personalized care and individualized integrated protocols to give her patients accurate knowledge, empowering them to make informed decisions.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Penny Daugherty RN, MS, OCN, ONN-CG – Faculty/Content Reviewer, has disclosed no financial relationships.
Sharyn Lewin, MD – Faculty/Content Reviewer, has disclosed no financial relationships.
Elizabeth Ramaccia – Content Writer, has disclosed no financial relationships.
Dorothy Caputo, MA, BSN, RN – AKH CE Director of Accreditations, has disclosed no financial relationships.
Trish Brignoni, AKH Director of Operations, has disclosed no financial relationships.
AKH and dandelionRX Planners and Reviewers, have disclosed no financial relationships.
This activity is supported by educational grants from Tesaro | A GSK Company.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.
Copyright 2021 AKH Inc. No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher